The table below provides the definition for this International Classification of Childhood Cancer, Third edition (IARC 2017) variable. To see other variable definitions, see the ICCC home page.
The information provided in this table is also available to download (XLSX, 24 KB).
Site Group | ICD-O-3 Histology | ICD-O-3 Primary Site | ICD-O-3 Behavior | Extended Recode | Regular Recode |
---|---|---|---|---|---|
I. Leukemias, Myeloproliferative And Myelodysplastic Diseases | |||||
(a) Lymphoid leukemias | |||||
(a.1) Precursor cell leukemias | 9811-9818, 9837 | 420, 421, 423, 424, 809 | 3 | 001 | 011 |
9835, 9836 | 000-809 | 3 | 001 | 011 | |
(a.2) Mature B-cell leukemias | 9823 | 420, 421, 423, 424, 809 | 3 | 002 | 011 |
9826, 9832, 9833, 9940 | 000-809 | 3 | 002 | 011 | |
(a.3) Mature T-cell and NK cell leukemias | 9827 | 420, 421, 423, 424, 809 | 3 | 003 | 011 |
9831, 9834, 9948 | 000-809 | 3 | 003 | 011 | (a.4) Lymphoid leukemia, NOS | 9591 | 420, 421, 423, 424 | 3 | 004 | 011 |
9820 | 000-809 | 3 | 004 | 011 | |
(b) Acute myeloid leukemias | 9840, 9861, 9865-9867, 9869-9874, 9891, 9895-9897, 9898, 9910, 9911, 9920, 9930, 9931 | 000-809 | 3 | 005 | 012 |
(c) Chronic myeloproliferative diseases | 9863, 9875, 9876, 9950, 9960-9964 | 000-809 | 3 | 006 | 013 |
(d) Myelodysplastic syndrome and other myeloproliferative diseases | 9945, 9946, 9975, 9980, 9982-9987, 9989, 9991, 9992 | 000-809 | 3 | 007 | 014 |
(e) Unspecified and other specified leukemias | 9800, 9801, 9805-9809, 9860, 9965-9967 | 000-809 | 3 | 008 | 015 |
II. Lymphomas and reticuloendothelial neoplasms | |||||
(a) Hodgkin lymphomas | 9650-9655, 9659, 9661-9665, 9667 | 000-809 | 3 | 009 | 021 |
(b) Non-Hodgkin lymphomas (except Burkitt lymphoma) | |||||
(b.1) Precursor cell lymphomas | 9727-9729 | 000-809 | 3 | 010 | 022 |
9811-9818, 9837 | 000-419, 422, 440-779 | 3 | 010 | 022 | |
(b.2) Mature B-cell lymphomas (except Burkitt lymphoma) | 9597, 9670, 9671, 9673, 9675, 9678-9680, 9684, 9688-9691, 9695, 9698, 9699, 9712, 9731-9735, 9737, 9738, 9761, 9762, 9764-9766, 9769, 9970, 9971 | 000-809 | 3 | 011 | 022 |
9823 | 000-419, 422, 440-779 | 3 | 011 | 022 | |
(b.3) Mature T-cell and NK-cell lymphomas | 9700-9702, 9705, 9708, 9709, 9714, 9716-9719, 9724-9726, 9767, 9768 | 000-809 | 3 | 012 | 022 |
9827 | 000-419, 422, 440-779 | 3 | 012 | 022 | |
(b.4) Non-Hodgkin lymphomas, NOS | 9591 | 000-419, 422, 440-779, 809 | 3 | 013 | 022 |
9760 | 000-809 | 3 | 013 | 022 | |
(c) Burkitt lymphoma | 9687 | 000-809 | 3 | 014 | 023 |
(d) Miscellaneous lymphoreticular neoplasms | 9740-9742, 9750, 9751, 9754-9759 | 000-809 | 3 | 015 | 024 |
(e) Unspecified lymphomas | 9590, 9596 | 000-809 | 3 | 016 | 025 |
III. CNS and Miscellaneous Intracranial and Intraspinal Neoplasms | |||||
(a) Ependymomas and choroid plexus tumor | |||||
(a.1) Ependymomas | 9383, 9391-9394, 9396 | 000-809 | 0-1, 3 | 017 | 031 |
(a.2) Choroid plexus tumor | 9390 | 000-809 | 0-1, 3 | 018 | 031 |
(b) Astrocytomas | 9380 | 723 | 0-1, 3 | 019 | 032 |
9384, 9400-9411, 9420-9424, 9425, 9440-9442 | 000-809 | 0-1, 3 | 019 | 032 | |
(c) Intracranial and intraspinal embryonal tumors | |||||
(c.1) Medulloblastomas | 9470-9472, 9474-9478, 9480 | 000-809 | 0-1, 3 | 020 | 033 |
(c.2) Primitive neuroectodermal tumor (PNET) | 9473 | 000-809 | 0-1, 3 | 021 | 033 |
(c.3) Medulloepithelioma | 9501-9504 | 700-729 | 0-1, 3 | 022 | 033 |
(c.4) Atypical teratoid/rhabdoid tumor | 9508 | 000-809 | 0-1, 3 | 023 | 033 |
(d) Other gliomas | |||||
(d.1) Oligodendrogliomas | 9450, 9451, 9460 | 000-809 | 0-1, 3 | 024 | 034 |
(d.2) Mixed and unspecified gliomas | 9380 | 700-722, 724-729, 751, 753 | 0-1, 3 | 025 | 034 |
9382, 9385 | 000-809 | 0-1, 3 | 025 | 034 | |
(d.3) Neuroepithelial glial tumors of uncertain origin | 9381, 9430, 9431, 9444, 9445 | 000-809 | 0-1, 3 | 026 | 034 |
(e) Other specified intracranial and intraspinal neoplasms | |||||
(e.1) Pituitary adenomas and carcinomas | 8158, 8290 | 751 | 0-1, 3 | 027 | 035 |
8270-8281, 8300 | 000-809 | 0-1, 3 | 027 | 035 | |
(e.2) Tumours of the sellar region (craniopharyngiomas) | 9350-9352, 9432, 9582 | 000-809 | 0-1, 3 | 028 | 035 |
(e.3) Pineal parenchymal tumors | 9360-9362, 9395 | 000-809 | 0-1, 3 | 029 | 035 |
(e.4) Neuronal and mixed neuronal-glial tumors | 9412, 9413, 9492, 9493, 9505-9507, 9509 | 000-809 | 0-1, 3 | 030 | 035 |
(e.5) Meningiomas | 9530-9539 | 000-809 | 0-1, 3 | 031 | 035 |
(f) Unspecified intracranial and intraspinal neoplasms | 8000-8005 | 700-729, 751-753 | 0-1, 3 | 032 | 036 |
IV. Neuroblastoma And Other Peripheral Nervous Cell Tumors | |||||
(a) Neuroblastoma and ganglioneuroblastoma | 9490, 9500 | 000-809 | 3 | 033 | 041 |
(b) Other peripheral nervous cell tumors | 8680-8683, 8690-8693, 8700, 9520-9523 | 000-809 | 3 | 034 | 042 |
9501-9504 | 000-699, 739-768, 809 | 3 | 034 | 042 | |
V. Retinoblastoma | 9510-9514 | 000-809 | 3 | 035 | 050 |
VI. Renal Tumors | |||||
(a) Nephroblastoma and other non-epithelial renal tumors | |||||
(a.1) Nephroblastoma | 8959, 8960 | 000-809 | 3 | 036 | 061 |
(a.2) Rhabdoid renal tumor | 8963 | 649 | 3 | 037 | 061 |
(a.3) Kidney sarcomas | 8964-8967 | 000-809 | 3 | 038 | 061 |
(b) Renal carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8155, 8190-8201, 8210, 8211, 8221-8231, 8240, 8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8325, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8562, 8570-8573, 9013 | 649 | 3 | 039 | 062 |
8311, 8312, 8316-8319, 8361 | 000-809 | 3 | 039 | 062 | |
(c) Unspecified malignant renal tumors | 8000-8005 | 649 | 3 | 040 | 063 |
VII. Hepatic Tumors | |||||
(a) Hepatoblastoma and mesenchymal tumors of liver | |||||
(a.1) Hepatoblastoma | 8970, 8975 | 000-809 | 3 | 041 | 071 |
(a.2) Rhabdoid hepatic tumor | 8963 | 220, 221 | 3 | 042 | 071 |
(a.3) Embryonal sarcoma of liver | 8991 | 220, 221 | 3 | 043 | 071 |
(b) Hepatic carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8140, 8141, 8143, 8148, 8155, 8158, 8190-8201, 8202, 8210, 8211, 8230, 8231, 8240, 8241, 8244-8246, 8260-8264, 8310, 8320, 8323, 8401, 8430, 8440, 8470, 8480-8490, 8503, 8504, 8510, 8550, 8560-8562, 8570-8573, 9013 | 220, 221 | 3 | 044 | 072 |
8160-8162, 8170-8180 | 000-809 | 3 | 044 | 072 | |
(c) Unspecified malignant hepatic tumors | 8000-8005 | 220, 221 | 3 | 045 | 073 |
VIII. Malignant Bone Tumors | |||||
(a) Osteosarcomas | 9180-9187, 9191-9195, 9200 | 400-419, 760-768, 809 | 3 | 046 | 081 |
(b) Chondrosarcomas | 9210, 9220, 9240 | 400-419, 760-768, 809 | 3 | 047 | 082 |
9211-9213, 9221, 9222, 9230, 9241-9243 | 000-809 | 3 | 047 | 082 | |
9231 | 400-419 | 3 | 047 | 082 | |
(c) Ewing tumor and related sarcomas of bone | |||||
(c.1) Ewing tumor and Askin tumor of bone | 9260 | 400-419, 760-768, 809 | 3 | 048 | 083 |
9365 | 400-419 | 3 | 048 | 083 | |
(c.2) Peripheral neuroectodermal tumor (pPNET) of bone | 9364 | 400-419 | 3 | 049 | 083 |
(d) Other specified malignant bone tumors | |||||
(d.1) Malignant fibrous neoplasms of bone | 8810, 8811, 8818, 8823, 8830 | 400-419 | 3 | 050 | 084 |
8812, 9262 | 000-809 | 3 | 050 | 084 | |
(d.2) Malignant chordomas | 9370-9372 | 000-809 | 3 | 051 | 084 |
(d.3) Odontogenic malignant tumors | 9270-9275, 9280-9282, 9290, 9300-9302, 9310-9312, 9320-9322, 9330, 9340-9342 | 000-809 | 3 | 052 | 084 |
(d.4) Miscellaneous malignant bone tumors | 9250, 9261 | 000-809 | 3 | 053 | 084 |
(e) Unspecified malignant bone tumors | 8000-8005, 8800, 8801, 8803-8805 | 400-419 | 3 | 054 | 085 |
IX. Soft Tissue And Other Extraosseous Sarcomas | |||||
(a) Rhabdomyosarcomas | 8900-8905, 8910, 8912, 8920 | 000-809 | 3 | 055 | 091 |
8991 | 000-218, 239-809 | 3 | 055 | 091 | |
(b) Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms | |||||
(b.1) Fibroblastic and myofibroblastic tumors | 8810, 8811, 8813-8817, 8821, 8823, 8834-8835 | 000-399, 440-768, 809 | 3 | 056 | 092 |
8820, 8822, 8824-8828, 9150, 9160 | 000-809 | 3 | 056 | 092 | |
(b.2) Nerve sheath tumors | 9540-9571 | 000-809 | 3 | 057 | 092 |
(b.3) Other fibromatous neoplasms | 9491, 9580 | 000-809 | 3 | 058 | 092 |
(c) Kaposi sarcoma | 9140 | 000-809 | 3 | 059 | 093 |
(d) Other specified soft tissue sarcomas | |||||
(d.1) Ewing tumor and Askin tumor of soft tissue | 9260 | 000-399, 440-449, 470-759 | 3 | 060 | 094 |
9365 | 000-399, 470-639, 659-768, 809 | 3 | 060 | 094 | |
(d.2) Peripheral neuroectodermal tumor (pPNET) of soft tissue | 9364 | 000-399, 440-449, 470-699, 739-768, 809 | 3 | 061 | 094 |
(d.3) Extrarenal extrahepatic rhabdoid tumor | 8963 | 000-218, 239-639, 659-699, 739-768, 809 | 3 | 062 | 094 |
(d.4) Liposarcomas | 8850-8858, 8860-8862, 8870, 8880, 8881 | 000-809 | 3 | 063 | 094 |
(d.5) Fibrohistiocytic tumors | 8830 | 000-399, 440-768, 809 | 3 | 064 | 094 |
8831-8833, 8836, 9251, 9252 | 000-809 | 3 | 064 | 094 | |
(d.6) Leiomyosarcomas | 8890-8898 | 000-809 | 3 | 065 | 094 |
(d.7) Synovial sarcomas | 9040-9044 | 000-809 | 3 | 066 | 094 |
(d.8) Blood vessel tumors | 9120-9125, 9130-9133, 9135-9138, 9141, 9142, 9161, 9170-9175 | 000-809 | 3 | 067 | 094 |
(d.9) Osseous and chondromatous neoplasms of soft tissue | 9180-9187, 9191-9195, 9200, 9210, 9220, 9240 | 220, 300-388, 470-509, 600-619, 649, 670-679, 696, 700-729 | 3 | 068 | 094 |
9231 | 000-399, 440-768, 809 | 3 | 068 | 094 | |
(d.10) Alveolar soft parts sarcoma | 9581 | 000-809 | 3 | 069 | 094 |
(d.11) Miscellaneous soft tissue sarcomas | 8587, 8710-8714, 8806, 8840-8842, 8921, 8990, 8992, 9045, 9373 | 000-809 | 3 | 070 | 094 |
(e) Unspecified soft tissue sarcomas | 8800-8805 | 000-399, 440-768, 809 | 3 | 071 | 095 |
X. Germ Cell Tumors, Trophoblastic Tumors And Neoplasms Of Gonads | |||||
(a) Intracranial and intraspinal germ cell tumors | |||||
(a.1) Intracranial and intraspinal germinomas | 9060-9065 | 700-729, 751-753 | 0-1, 3 | 072 | 101 |
(a.2) Intracranial and intraspinal teratomas | 9080-9084 | 700-729, 751-753 | 0-1, 3 | 073 | 101 |
(a.3) Intracranial and intraspinal embryonal carcinomas | 9070, 9072 | 700-729, 751-753 | 0-1, 3 | 074 | 101 |
(a.4) Intracranial and intraspinal yolk sac tumor | 9071 | 700-729, 751-753 | 0-1, 3 | 075 | 101 |
(a.5) Intracranial and intraspinal choriocarcinoma | 9100, 9101 | 700-729, 751-753 | 0-1, 3 | 076 | 101 |
(a.6) Intracranial and intraspinal tumors of mixed forms | 9085 | 700-729, 751-753 | 0-1, 3 | 077 | 101 |
(b) Malignant extracranial and extragonadal germ cell tumors | |||||
(b.1) Malignant germinomas of extracranial and extragonadal sites | 9060-9065 | 000-559, 570-619, 630-699, 739-750, 754-768, 809 | 3 | 078 | 102 |
(b.2) Malignant teratomas of extracranial and extragonadal sites | 9080-9084 | 000-559, 570-619, 630-699, 739-750, 754-768, 809 | 3 | 079 | 102 |
(b.3) Embryonal carcinomas of extracranial and extragonadal sites | 9070, 9072 | 000-559, 570-619, 630-699, 739-750, 754-768, 809 | 3 | 080 | 102 |
(b.4) Yolk sac tumor of extracranial and extragonadal sites | 9071 | 000-559, 570-619, 630-699, 739-750, 754-768, 809 | 3 | 081 | 102 |
(b.5) Choriocarcinomas of extracranial and extragonadal sites | 9100, 9101, 9103-9105 | 000-559, 570-619, 630-699, 739-750, 754-768, 809 | 3 | 082 | 102 |
(b.6) Oth/unspec malig mixed germ cell tumors of extracranial/extragonadal | 9085, 9086 | 000-559, 570-619, 630-699, 739-750, 754-768, 809 | 3 | 083 | 102 |
(c) Malignant gonadal germ cell tumors | |||||
(c.1) Malignant gonadal germinomas | 9060-9065 | 569, 620-629 | 3 | 084 | 103 |
(c.2) Malignant gonadal teratomas | 9080-9084, 9090, 9091 | 569, 620-629 | 3 | 085 | 103 |
(c.3) Gonadal embryonal carcinomas | 9070, 9072 | 569, 620-629 | 3 | 086 | 103 |
(c.4) Gonadal yolk sac tumor | 9071 | 569, 620-629 | 3 | 087 | 103 |
(c.5) Gonadal choriocarcinoma | 9100-9105 | 569, 620-629 | 3 | 088 | 103 |
(c.6) Malignant gonadal tumors of mixed forms | 9085 | 569, 620-629 | 3 | 089 | 103 |
(c.7) Malignant gonadal gonadoblastoma | 9073 | 569, 620-629 | 3 | 090 | 103 |
(d) Gonadal carcinomas | 8010-8041, 8044, 8050-8075, 8082, 8120-8123, 8130-8141, 8143, 8153, 8190-8201, 8210, 8211, 8213, 8221-8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8380-8384, 8430, 8440-8442, 8450, 8470, 8480-8490, 8504, 8510, 8550, 8560-8562, 8570-8573, 9000, 9014 | 569, 620-629 | 3 | 091 | 104 |
8313, 8443, 8444, 8451, 8474, 9015 | 000-809 | 3 | 091 | 104 | |
8158, 8243, 8410, 8452, 8460-8463, 8471-8473, 8576 | 569 | 3 | 091 | 104 | |
(e) Other and unspecified malignant gonadal tumors | 8590-8671 | 000-809 | 3 | 092 | 105 |
8000-8005 | 569, 620-629 | 3 | 092 | 105 | |
XI. Other Malignant Epithelial Neoplasms And Malignant Melanomas | |||||
(a) Adrenocortical carcinomas | 8158 | 740 | 3 | 093 | 111 |
8370-8375 | 000-809 | 3 | 093 | 111 | |
(b) Thyroid carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8158, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8324, 8333, 8430, 8440, 8480, 8481, 8510, 8560-8562, 8570-8573, 8589 | 739 | 3 | 094 | 112 |
8330-8332, 8334-8337, 8340-8347, 8350, 8588 | 000-809 | 3 | 094 | 112 | |
(c) Nasopharyngeal carcinomas | 8010-8041, 8050-8075, 8082, 8083, 8120-8122, 8130-8141, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440,8480, 8481, 8500-8551, 8560-8562, 8570-8576 | 110-119 | 3 | 095 | 113 |
(d) Malignant melanomas | 8720-8780, 8790 | 000-809 | 3 | 096 | 114 |
(e) Skin carcinomas | 8010-8041, 8050-8075, 8078, 8081, 8082, 8090-8098, 8100-8110, 8140, 8143, 8147, 8190, 8200, 8211, 8240, 8246, 8247, 8260, 8263, 8310, 8320, 8323, 8390-8420, 8430, 8480, 8540, 8542, 8560, 8570-8573 | 440-449, 519, 609, 632 | 3 | 097 | 115 |
(f) Other and unspecified carcinomas | |||||
(f.1) Carcinomas of salivary glands | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 079-089 | 3 | 098 | 116 |
(f.2) Carcinomas of colon and rectum | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 180, 182-189, 199, 209, 210-218 | 3 | 099 | 116 |
(f.3) Carcinomas of appendix | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 181 | 3 | 100 | 116 |
(f.4) Carcinomas of lung | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333,8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 340-349 | 3 | 101 | 116 |
(f.5) Carcinomas of thymus | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 379 | 3 | 102 | 116 |
(f.6) Carcinomas of breast | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 500-509 | 3 | 103 | 116 |
(f.7) Carcinomas of cervix uteri | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 530-539 | 3 | 104 | 116 |
(f.8) Carcinomas of bladder | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 670-679 | 3 | 105 | 116 |
(f.9) Carcinomas of eye | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 690-699 | 3 | 106 | 116 |
(f.10) Carcinomas of other specified sites | 8010-8077, 8080-8086, 8098, 8120-8157, 8163, 8190-8265, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 000-069, 090-109, 129-179, 239-339, 380-399, 480-488, 510-518, 529, 540-559, 570-608, 619, 630-631, 637-639, 659-669, 680-689, 700-729, 750-759 | 3 | 107 | 116 |
8158, 8290 | 000-069, 090-109, 129-179, 239-339, 380-399, 480-488, 510-529, 540-559, 570-619, 630-639, 659-669, 680-689, 750, 752-759 | 3 | 107 | 116 | |
(f.11) Carcinomas of unspecified site | 8010-8077, 8080-8086, 8098, 8120-8158, 8163, 8190-8265, 8290, 8310, 8314-8315, 8320-8324, 8333, 8360, 8380-8384, 8401, 8402, 8405, 8406, 8410, 8430-8442, 8450, 8452-8454, 8460, 8461, 8470, 8480-8586, 8589, 8941, 8983, 9000, 9010-9014, 9016, 9020, 9030 | 760-768, 809 | 3 | 108 | 116 |
XII. Other And Unspecified Malignant Neoplasms | |||||
(a) Other specified malignant tumors | |||||
(a.1) Malignant gastrointestinal stromal tumor | 8936 | 000-809 | 3 | 109 | 121 |
(a.2) Pancreatoblastoma | 8971 | 000-809 | 3 | 110 | 121 |
(a.3) Pulmonary blastoma and pleuropulmonary blastoma | 8972, 8973 | 000-809 | 3 | 111 | 121 |
(a.4) Other complex mixed and stromal neoplasms | 8930-8935, 8940, 8950, 8951, 8974, 8980-8982 | 000-809 | 3 | 112 | 121 |
(a.5) Mesothelioma | 9050-9055 | 000-809 | 3 | 113 | 121 |
(a.6) Other specified malignant tumors | 9110, 9363 | 000-809 | 3 | 114 | 121 |
(b) Other unspecified malignant tumors | 8000-8005 | 000-218, 239-399, 420-559, 570-619, 630-639, 659-699, 739-750, 754-809 | 3 | 115 | 122 |
Not classified by SEER or in situ | 999 | 999 |
1. Steliarova-Foucher E, Colombet M, Ries LAG, Rous B, Stiller CA. Classification of tumours. In: Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Shin HY, Hesseling P, Stiller CA. International Incidence of Childhood Cancer, Volume III. Lyon: International Agency for Research on Cancer, In press.